Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse

ConclusionThese results suggest the potential utility of cfDNA in the PB plasma of patients as a relevant early biomarker for MM relapse.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research